MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-OD-07-0008096
Albirus Pharmaceuticals Private Limited
Albirus Pharmaceuticals Private Limited - pharma in Cuttack, Odisha, India. FY 2026 financials & compliance.
Revenue · FY 2021
₹24.18 Lakh
▲ 94% YoY
Net profit · FY 2021
₹77,132
Net margin 3.2%
EBITDA · FY 2021
₹1.36 Lakh
EBITDA margin 5.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹19 Lakh
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
3
As per MCA filings
About Albirus Pharmaceuticals Private Limited
Data last updated:
Albirus Pharmaceuticals Private Limited is a private limited company based in Cuttack, Odisha, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U51909OR2018PTC029428. Its GSTIN is 21AARCA2785N1Z6 (Odisha).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Upasana Sinha and Amit Kumar Sinha.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Plot No – 1854 K N – 1250 At – Kathagada Sahi Po – Buxibazar Ps – Purighat Cuttack Sadar, Odisha, India – 753001.
As per the financials filed for FY 2021, the company reported a revenue of ₹24.18 Lakh, a growth of 94% compared to the previous year. For the same year it recorded a net profit of ₹77,132 (net margin 3.2%) and EBITDA of ₹1.36 Lakh (EBITDA margin 5.6%).
As per MCA filings, the company has open charges of ₹19 Lakh on record.
Albirus Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-OD-07-0008096).
Company Details of Albirus Pharmaceuticals Private Limited
CIN U51909OR2018PTC029428
Registration Number 029428
Incorporation Date 08 September 2018
ROC Cuttack
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2021
MSME Classification Micro
Udyam Registration UDYAM-OD-07-0008096
Recognitions & Rankings of Albirus Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No – 1854 K N – 1250 At – Kathagada Sahi Po – Buxibazar Ps – Purighat Cuttack Sadar, Odisha, India – 753001
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Albirus Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Albirus Pharmaceuticals Private Limited
The main business activity of Albirus Pharmaceuticals is construction. In detail, this covers buildings.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| F | Construction | F1 | Buildings | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Albirus Pharmaceuticals Private Limited FY 2021 filings available
Albirus Pharmaceuticals Private Limited reported revenue of ₹24.18 Lakh (up 94% YoY) for FY 2021.
Revenue · FY 2021
₹24.18 Lakh ▲ 94%
Net profit · FY 2021
₹77,132 margin 3.2%
EBITDA · FY 2021
₹1.36 Lakh margin 5.6%
Compounded Annual Growth Rate (CAGR) of Albirus Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 94%
EBITDA CAGR growth
1 year
▲ 184%
Revenue rose 94% in the latest year. EBITDA rose 184% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Albirus Pharmaceuticals Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹1.36 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹77,132 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Albirus Pharmaceuticals Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 5.6% | •••• | •••• |
| Net Profit Margin | 3.2% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Albirus Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Albirus Pharmaceuticals Private Limited
Albirus Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Upasana Sinha Also directs: Debarati Agro Foods Private Limited | Director | 16 Jan 2024 | 2 Years 9 Months | Current |
| Amit Kumar Sinha | Director | 08 Sep 2018 | 8 Years 1 Months | Current |
| Ashis Sinha | Director | 22 Dec 2025 | 0 Years 9 Months | Current |
Peer Comparison of Albirus Pharmaceuticals Private Limited
Albirus Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Griya Sri Pharma Private Limited | ₹24.29 Lakh (FY 2024) | •••• | •••• | -13.0% | •••• | Chennai, Tamil Nadu, India |
| Pravir Pharmaceuticals Private Limited | ₹24.27 Lakh (FY 2021) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Sainbiomed Private Limited | ₹24.2 Lakh (FY 2022) | •••• | •••• | 19.0% | •••• | Dehradun, Uttarakhand, India |
| Mway Pharmaceuticals Private Limited | ₹24.19 Lakh (FY 2018) | •••• | •••• | 2570.0% | •••• | Raipur, Chhattisgarh, India |
| Medyvine Pharmaceuticals Private Limited | ₹24.19 Lakh (FY 2024) | •••• | •••• | -27.0% | •••• | Delhi, India |
| Albirus Pharmaceuticals Private Limited this company | ₹24.18 Lakh (FY 2021) | •••• | •••• | 94.0% | •••• | Cuttack, Odisha, India |
| Mackley Bioscience Private Limited | ₹24.18 Lakh (FY 2025) | •••• | •••• | -14.0% | •••• | Jaipur, Rajasthan, India |
| RPVP Pharmaceuticals Private Limited | ₹24.17 Lakh (FY 2025) | •••• | •••• | -30.0% | •••• | Singrauli, Madhya Pradesh, India |
| I2 Private Limited | ₹24.15 Lakh (FY 2025) | •••• | •••• | 78.0% | •••• | New Delhi, Delhi, India |
| Uni Biotech Pharmaceuticals Private Limited | ₹24.15 Lakh (FY 2025) | •••• | •••• | -84.0% | •••• | Chennaai, Tamil Nadu, India |
| Vetbn Pharmaceuticals Private Limited | ₹24.15 Lakh (FY 2022) | •••• | •••• | -32.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Albirus Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Albirus Pharmaceuticals Private Limited
Albirus Pharmaceuticals Private Limited is audited by A K LENKA & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A K LENKA & CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Albirus Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Albirus Pharmaceuticals Private Limited
Open charges
₹19 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Apr 2024 | Canara Bank | ₹10 Lakh | Open |
| 30 Aug 2021 | Others | ₹9 Lakh | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Albirus Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Albirus Pharmaceuticals.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Albirus Pharmaceuticals Private Limited
Albirus Pharmaceuticals Private Limited has 7 board changes on record since 2018: 3 appointments and 4 cessations. The latest: Ashis Sinha was appointed as Director on 22 Dec 2025.
Appointed
Ashis Sinha was appointed as Director.
AGM
Albirus Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
A charge with Canara Bank amounted to Rs. 10.00 Lakh with Charge ID 100906103 was registered on 06 Apr 2024.
Ceased
Ashis Sinha ceased to be Managing Director.
Appointed
Upasana Sinha was appointed as Director.
Ceased
Man Kumar Das ceased to be Director.
Ceased
Uma Shankar Mishra ceased to be Director.
Charges
A charge with Others amounted to Rs. 9.00 Lakh with Charge ID 100485622 was registered on 30 Aug 2021.
Filing
Albirus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Cuttack.
Ceased
Jaganath Nirupama Debashirbad Das ceased to be Director.
Appointed
Amit Kumar Sinha was appointed as Director.
Incorporation
08 Sep 2018
Albirus Pharmaceuticals Private Limited was registered on 08 Sep 2018 with Roc Cuttack & aged 8 years 1 month as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Albirus Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Albirus Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Albirus Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Albirus Pharmaceuticals Private Limited
Albirus Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AARCA2785N1Z6 | Odisha | Active | 08 Apr 2019 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Albirus Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Albirus Pharmaceuticals Private Limited
Albirus Pharmaceuticals is an active private limited company based in Cuttack, Odisha, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 September 2018 (8+ years old) and is registered under CIN U51909OR2018PTC029428.
Albirus Pharmaceuticals reported revenue of ₹24.18 Lakh for FY 2021 (up 94% YoY).
Albirus Pharmaceuticals has 3 current directors:
- Upasana Sinha - Director
- Amit Kumar Sinha - Director
- Ashis Sinha - Director
Albirus Pharmaceuticals reported a net profit of ₹77,132 (net margin 3.2%) and EBITDA of ₹1.36 Lakh (EBITDA margin 5.6%) for FY 2021, as per its filed financial statements.
The GSTIN of Albirus Pharmaceuticals is 21AARCA2785N1Z6, registered in Odisha.
The CIN (Corporate Identification Number) of Albirus Pharmaceuticals is U51909OR2018PTC029428. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Albirus Pharmaceuticals was incorporated on 08 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Albirus Pharmaceuticals by revenue are Griya Sri Pharma Private Limited, Pravir Pharmaceuticals Private Limited, Sainbiomed Private Limited, Mway Pharmaceuticals Private Limited, Medyvine Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Ashis Sinha was appointed as Director on 22 Dec 2025. Ashis Sinha ceased to be Managing Director on 18 Jan 2024. Upasana Sinha was appointed as Director on 16 Jan 2024. Albirus Pharmaceuticals has 7 board changes on record in total.
Yes, Albirus Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-OD-07-0008096).
The registered office of Albirus Pharmaceuticals is at Plot No – 1854 K N – 1250 At – Kathagada Sahi Po – Buxibazar Ps – Purighat Cuttack Sadar, Odisha, India – 753001.